IPSC compared with LBRX: revenue, margins and what each company keeps, and the suppliers and customers both name

IPSCCentury Therapeutics, Inc.

Mkt capRevenueRevenue

LBRXLB Pharmaceuticals Inc

Mkt capRevenueRevenue

Compare

IPSCCentury Therapeutics, Inc.

LBRXLB Pharmaceuticals Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only IPSC 7

BMYBristol-Myers Squibbcustomer

—FUJIFILM Cellular Dynamicsunlistedsupplier

—Catalent Dusseldorf GmbHunlistedsupplier

—Fcdiunlistedsupplier

3 more · IPSC chain ›

Shared 0

No disclosed counterparties: LBRX.

Only LBRX 0

None

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

IPSCCentury Therapeutics, Inc.

1.67▲+9.87%· post 1.67· delayed

Mkt cap$275.2MRevenue$109MQ1 FY25Revenue$7MFY24

LBRXLB Pharmaceuticals Inc

40.12▼−0.53%· post 40.12· delayed

After hoursNov 4 '26delayed

Mkt cap$1.2BRevenue—Revenue—

Compare

After hoursNov 4 '26delayed

IPSCCentury Therapeutics, Inc.

LBRXLB Pharmaceuticals Inc

1.67▲+9.87%post 1.67delayed

Price

40.12▼−0.53%post 40.12delayed

$275.2M

Mkt cap

$1.2B

Q1 FY25$109M

Revenue

—

FY24$7M

Revenue

—

IPSC1.67▲+9.87%vsLBRX40.12▼−0.53%After hoursNov 4 '26delayed